Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) saw an uptick in trading volume on Monday . 485,224 shares changed hands during mid-day trading, an increase of 17% from the previous session’s volume of 414,685 shares.The stock last traded at $5.08 and had previously closed at $4.88.

A number of brokerages have commented on CLMT. Cowen and Company lifted their price objective on shares of Calumet Specialty Products Partners, L.P from $5.00 to $10.00 and gave the stock a “market perform” rating in a research note on Thursday, May 5th. Zacks Investment Research cut shares of Calumet Specialty Products Partners, L.P from a “hold” rating to a “sell” rating in a research note on Monday. Credit Suisse Group AG cut shares of Calumet Specialty Products Partners, L.P from an “outperform” rating to an “underperform” rating and dropped their price objective for the stock from $32.00 to $11.00 in a research note on Monday, April 11th. Janney Montgomery Scott cut shares of Calumet Specialty Products Partners, L.P from a “buy” rating to a “neutral” rating and dropped their price objective for the stock from $17.00 to $8.00 in a research note on Monday, April 18th. Finally, Howard Weil dropped their price objective on shares of Calumet Specialty Products Partners, L.P from $19.00 to $5.00 and set a “sector underperform” rating for the company in a research note on Monday, April 18th. Six research analysts have rated the stock with a sell rating and nine have given a hold rating to the stock. The stock has an average rating of “Hold” and an average price target of $10.71.

The company’s market capitalization is $384.57 million. The firm’s 50 day moving average price is $4.73 and its 200 day moving average price is $7.98.

Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) last released its earnings results on Thursday, August 4th. The company reported ($1.89) EPS for the quarter, missing analysts’ consensus estimates of ($0.34) by $1.55. Equities research analysts forecast that Calumet Specialty Products Partners, L.P will post ($1.84) earnings per share for the current fiscal year.

In other Calumet Specialty Products Partners, L.P news, Director Stephen P. Mawer bought 11,000 shares of Calumet Specialty Products Partners, L.P stock in a transaction on Wednesday, May 18th. The stock was bought at an average price of $3.68 per share, with a total value of $40,480.00. Following the completion of the acquisition, the director now owns 5,025 shares in the company, valued at $18,492. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Timothy Go bought 25,000 shares of Calumet Specialty Products Partners, L.P stock in a transaction on Thursday, May 12th. The stock was acquired at an average cost of $3.82 per share, with a total value of $95,500.00. Following the acquisition, the chief executive officer now owns 27,607 shares of the company’s stock, valued at approximately $105,458.74. The disclosure for this purchase can be found here.

A hedge fund recently raised its stake in Calumet Specialty Products Partners, L.P stock. Morgan Stanley raised its position in shares of Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) by 51.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 860,510 shares of the company’s stock after buying an additional 293,839 shares during the period. Morgan Stanley owned 1.14% of Calumet Specialty Products Partners, L.P worth $17,133,000 as of its most recent SEC filing.

Calumet Specialty Products Partners, L.P. is a producer of specialty hydrocarbon products. The Company operates through three segments. In its specialty products segment, the Company processes crude oil and other feedstocks into a range of customized lubricating oils, white mineral oils, solvents, petrolatums and waxes.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.